October 1998 - The CenterWatch Monthly : Volume 5, Issue 10, October 1998
Product Details
A Warming Relationship With MCO
A large percentage of patients who receive their primary care from a managed care organization are now participating in clinical trials though indirectly. A CenterWatch survey reveals that sponsors and CROs want to work more closely with staff-model MCOs over the next two years. Sponsor interest in MCOs is primarily for access to patients and rich data sources. A distant secondary interest is access to formulary.
Sponsors Evaluate Building In-House CROs
Sponsors report that they are becoming more selective in their use of CROsMany sponsors report that they are increasing their use of temporary agencies and independent contractors. About 42% of sponsors surveyed for this story said that they believe CRO costs are up to 25% more expensive than those of in-house resources.
Eye On: AIDS/HIV
CenterWatch editorial staff confirms 50 therapies in the pipeline for the treatment of AIDS, HIV and related illnesses.
- Month in Review
- TrialWatch